Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7581070 | 0.83 | CYP3A4 (0.38) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL7576053 | 0.81 | TSHR (0.43) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL3733702 | 0.79 | — | — | |
| SCHEMBL28981565 | 0.79 | CYP3A4 (0.42) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL7573067 | 0.79 | CYP3A4 (0.36) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL7573463 | 0.78 | CYP3A4 (0.38) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL7573054 | 0.78 | CYP3A4 (0.35) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL4888783 | 0.78 | TDP1 (0.38) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL10770832 | 0.78 | TSHR (0.44) | CYP3A4TDP1TSHRMAPTCACNA1B | |
| SCHEMBL7581410 | 0.78 | CYP3A4 (0.35) | CYP3A4TDP1TSHRMAPTCACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10273473-A | — | — | None | — | — | JP | disclosed |
| US-20020042055-A1 | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions | MAXYGEN, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001046476-A1 | ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS | MAXYGEN, INC. (US) | 2001-06-28 | — | — | WO | disclosed |
| JP-H10273473-A | PRODUCTION OF ALKALI METAL AND/OR AMMONIUM SALT OF ALPHA-CHLORO-ACRYLIC ACID AND/OR CROTONIC ACID | CLARIANT FINANCE BVI LTD | 1998-10-13 | — | — | JP | disclosed |
| US-4786645-A | ANTIALLERGENS, ANTIINFLAMMATORY | RHONE-POULENC SANTE (FR) | 1988-11-22 | — | — | US | disclosed |
| US-4783472-A | 1H,3H-pyrrol[1,2-c]thiazole derivatives and pharmaceutical compositions containing them | RHONE-POULENC SANTE (FR) | 1988-11-08 | — | — | US | disclosed |
| US-4072687-A | DEHYDROCHLORINATING S-(BETA-CARBOXY-BETA-CHLOROETHYL) ISOTHIOUREA | AJINOMOTO CO., INC. (JA) | 1978-02-07 | — | — | US | disclosed |